Tg Therapeutics
TGTX

Tg Therapeutics (TGTX) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
HC Wainwright & Co.MaintainedBuy$78.00Sep 1, 2026
JP MorganMaintainedOverweight$72.00 from $65.00Aug 7, 2026
B. Riley SecuritiesMaintainedBuy$86.00 from $55.00Jul 27, 2026
HC Wainwright & Co.MaintainedBuy$77.00 from $70.00Jul 13, 2026
B of A SecuritiesMaintainedUnderperform$20.00 from $17.00Jul 7, 2026
HC Wainwright & Co.MaintainedBuy$70.00Jul 6, 2026
HC Wainwright & Co.MaintainedBuy$70.00May 27, 2026
HC Wainwright & Co.MaintainedBuy$70.00 from $60.00May 6, 2026
JP MorganMaintainedOverweight$46.00 from $49.00Feb 2, 2026
Goldman SachsMaintainedNeutral$39.00 from $37.00Jan 15, 2026
JP MorganMaintainedOverweight$49.00 from $46.00Nov 3, 2025
HC Wainwright & Co.Initiated CoverageBuy$60.00Oct 6, 2025
B. Riley SecuritiesMaintainedBuy$55.00 from $53.00Sep 17, 2025
HC Wainwright & Co.MaintainedBuy$55.00Mar 4, 2025
HC Wainwright & Co.MaintainedBuy$55.00Jan 15, 2025
JP MorganMaintainedOverweight$43.00 from $30.00Nov 25, 2024
Goldman SachsMaintainedNeutral$22.00 from $20.00Nov 5, 2024
HC Wainwright & Co.MaintainedBuy$55.00 from $49.00Nov 5, 2024
TD CowenInitiated CoverageBuy$50.00Oct 29, 2024
HC Wainwright & Co.MaintainedBuy$49.00Sep 18, 2024

Frequently asked questions

  • What is the latest analyst rating on TGTX?

    On Sep 1, 2026, HC Wainwright & Co. maintained Tg Therapeutics at Buy with a price target of $78.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.